Kestenberg-Messina Kaitlin M.'s Form 4 filing
Adma Biologics, Inc. (ADMA) · filed Jul 28, 2026
- Accession no.
- 0001140361-26-029923
- Filed
- Jul 28, 2026, 9:00 PM ET
- Trade date
- Jul 24, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kestenberg-Messina Kaitlin M.CIK 0002017423 | Officer (COO and SVP, Compliance) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 24, 2026 | Common Stock | FTax withholdingDisposed | −3,177 | $8.37 | −$26,591.49 | 443,061 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.